ALLMedicine™ Hepatocellular Carcinoma Center

Dec 1st, 2020 - Due to the lack of early diagnostic and effective treatment modalities, hepatocellular carcinoma (HCC) is still the most lethal cancer with a high mortality on a global scale. Recent studies have highlighted the key roles of microRNAs (miRs) in HC...

Dec 1st, 2020 - While tumor burden (TB) has been associated with outcomes among patients with hepatocellular carcinoma, the role of overall TB in intrahepatic cholangiocarcinoma (ICC) remains poorly defined. Patients undergoing curative-intent resection of ICC be...

Dec 1st, 2020 - An increasing number of studies have focused on the association between leptin, adiponectin levels and the risk as well as the prognosis of hepatocellular carcinoma. However, the reported results are conflicting. A meta-analysis was performed to a...

Dec 1st, 2020 - Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multipl...

Dec 1st, 2020 - Priapism in a patient with advanced hepatocellular carcinoma.|2020|Kinoshita A,Koike K,Saruta M,|

Oct 8th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Jul 1st, 2020 - Donafenib, a deuterated derivative of sorafenib, was tested against sorafenib in the frontline setting in hepatitis B– associated hepatocellular carcinoma (HCC) in a large, multi-institutional study in China (Abstract 4506).

May 28th, 2020 - Donafenib significantly improved overall survival (OS) rates compared with sorafenib in patients with hepatocellular carcinoma (HCC) and did so with favorable safety and tolerability, according to a new study (Abstract 4506).

Dec 19th, 2019 - The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma (HCC) was published in 2018, and covered the diagnosis, management, tre...

Jun 17th, 2019 - Purpose of review To review the healthy protective effects of coffee against several metabolic diseases and some types of cancer. In this short review, the possible preventive and/or therapeutic actions of coffee on liver function is focused. Rec...

Dec 1st, 2020 - Due to the lack of early diagnostic and effective treatment modalities, hepatocellular carcinoma (HCC) is still the most lethal cancer with a high mortality on a global scale. Recent studies have highlighted the key roles of microRNAs (miRs) in HC...

Dec 1st, 2020 - While tumor burden (TB) has been associated with outcomes among patients with hepatocellular carcinoma, the role of overall TB in intrahepatic cholangiocarcinoma (ICC) remains poorly defined. Patients undergoing curative-intent resection of ICC be...

Dec 1st, 2020 - An increasing number of studies have focused on the association between leptin, adiponectin levels and the risk as well as the prognosis of hepatocellular carcinoma. However, the reported results are conflicting. A meta-analysis was performed to a...

Dec 1st, 2020 - Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multipl...

Dec 1st, 2020 - Priapism in a patient with advanced hepatocellular carcinoma.|2020|Kinoshita A,Koike K,Saruta M,|

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

Nov 19th, 2020 - NEW YORK (Reuters Health) - A new study highlights the growing rural-urban disparity in new cases of hepatocellular carcinoma (HCC) in the United States. HCC is the most common primary cancer of the liver and is currently the fastest growing cance...

Nov 19th, 2020 - NEW YORK (Reuters Health) - A new study highlights the growing rural-urban disparity in new cases of hepatocellular carcinoma (HCC) in the United States. HCC is the most common primary cancer of the liver and is currently the fastest growing cance...

Nov 18th, 2020 - For patients with chronic hepatitis B, the protective effects of aspirin against hepatocellular carcinoma (HCC) can vary with cirrhosis status and statin treatment, a pair of new studies finds. One study showed that although aspirin is linked to a...

Nov 18th, 2020 - For patients with chronic hepatitis B, the protective effects of aspirin against hepatocellular carcinoma (HCC) can vary with cirrhosis status and statin treatment, a pair of new studies finds. One study showed that although aspirin is linked to a...